Cite

HARVARD Citation

    Schwaab, J. et al. (n.d.). Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1‐JAK2, BCR‐JAK2 and ETV6‐ABL1 fusion genes. American journal of hematology. 95 (7), pp. 824-833. [Online]. 
  
Back to record